Marimed (MRMD) Total Non-Current Liabilities (2011 - 2025)

Marimed (MRMD) has 15 years of Total Non-Current Liabilities data on file, last reported at $137.8 million in Q4 2025.

• Total Non-Current Liabilities for Q4 2025 came in at $137.8 million, up 6.56% year-over-year; the trailing twelve-month figure through Dec 2025 was $137.8 million (up 6.56% YoY), and the FY2025 annual result was $137.8 million, up 6.56% from the prior year.
• Total Non-Current Liabilities improved to $137.8 million in Q4 2025 per MRMD's latest filing, from $136.5 million in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $137.8 million in Q4 2025 and troughed at $37.5 million in Q1 2021.
• A 5-year average of $89.3 million and a median of $89.2 million in 2023 frame the typical range for Total Non-Current Liabilities.
• The sharpest annual moves came in 2021 and 2023: Total Non-Current Liabilities slumped 36.32% in 2021, then jumped 87.69% in 2023.
• A 5-year view of Total Non-Current Liabilities shows it stood at $49.1 million in 2021, then rose by 16.27% to $57.1 million in 2022, then jumped by 87.69% to $107.1 million in 2023, then increased by 20.76% to $129.3 million in 2024, then rose by 6.56% to $137.8 million in 2025.
• Business Quant data shows MRMD's Total Non-Current Liabilities at $137.8 million in Q4 2025, $136.5 million in Q3 2025, and $131.1 million in Q2 2025.